• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Poult Sci . Delivery of dendritic cells targeting 3M2e-HA2 nanoparticles with a CpG adjuvant via lysosomal escape of Salmonella enhances protection

tetano

Editor, Senior Moderator
Poult Sci


. 2024 Dec 1;104(1):104616.
doi: 10.1016/j.psj.2024.104616. Online ahead of print. Delivery of dendritic cells targeting 3M2e-HA2 nanoparticles with a CpG adjuvant via lysosomal escape of Salmonella enhances protection against H9N2 avian influenza virus

Futing Jia[SUP] 1 [/SUP], Wenfeng Wang[SUP] 1 [/SUP], Yawen Tian[SUP] 1 [/SUP], Ainul Zahra[SUP] 1 [/SUP], Yingkai He[SUP] 1 [/SUP], Chongbo Ge[SUP] 1 [/SUP], Tongyu Zhang[SUP] 1 [/SUP], Mingyue Wang[SUP] 1 [/SUP], Jingshuo Gong[SUP] 1 [/SUP], Gerui Zhang[SUP] 1 [/SUP], Guilian Yang[SUP] 1 [/SUP], Wentao Yang[SUP] 1 [/SUP], Chunwei Shi[SUP] 1 [/SUP], Jianzhong Wang[SUP] 1 [/SUP], Haibin Huang[SUP] 1 [/SUP], Xin Cao[SUP] 1 [/SUP], Yang Zeng[SUP] 1 [/SUP], Nan Wang[SUP] 1 [/SUP], Zhannan Wang[SUP] 2 [/SUP], Chunfeng Wang[SUP] 3 [/SUP], Yanlong Jiang[SUP] 4 [/SUP]



Affiliations
Abstract

Avian influenza virus (AIV) subtype H9N2 still poses a great threat to the poultry farming industry and public health worldwide, and the development of a new influenza vaccine that is safe and conservative and able to address influenza virus mutations is highly promising for application. HA2, the neck of the HA protein, and M2e, the extracellular N-terminal structural domain of the M2 protein, are conserved and effective protective antigens. In this study, the HA2 sequences were fused with three M2e copies (H9N2, H1N1 and H5N1) to the norovirus VP1 protein via the SpyTag-SpyCatcher platform to form self-assembled nanoparticles and display antigenic proteins on its surface, yielding pYL262. The chicken dendritic cells (DCs) targeting the nanobody phage-54 were then fused to HA2-3M2e to yield pYL327. Finally, a synthesized 20-repeat CpG adjuvant gene fragment was inserted into pYL327, resulting in the plasmid pYL331. All the constructed plasmids were then transformed into the sifA gene-deficient Salmonella vector χYL56 for oral immunization. The results showed that sifA-deficient Salmonella could efficiently increase antigen-specific mucosal sIgA antibody titers, especially in alveolar lavage samples, whereas the presence of the phage-54 nanobody could dramatically increase intracellular IFN-γ mRNA levels, indicating its ability to enhance the Th1-type immune response. Finally, the presence of the CpG adjuvant clearly increased T-cell proliferation and promoted DC activation, with elevated splenic TLR21 levels observed. Strikingly, after oral immunization with χYL56 (pYL331), chickens were protected against challenge with the G57 genotype H9N2 virus, which presented similar or even better levels of virus shedding and body weight gain compared with the commercial inactivated vaccine, providing a new option for controlling H9N2 virus infection in the future.

Keywords: CpG adjuvant; Dendritic cell targeting; H9N2 influenza virus; Nanoparticle vaccine; SifA-mutant Salmonella.

 
Back
Top Bottom